Nonprofit issues challenge to accelerate treatments for every person with CF
Oct. 30, 2019
|
5 min read
The Cystic Fibrosis Foundation has increased its award to Arcturus Therapeutics to up to $15 million to develop a mutation-agnostic therapy for people with cystic fibrosis.
Aug. 5, 2019
|
2 min read
Preston W. Campbell, III, President and CEO to retire; Michael P. Boyle, MD, appointed as successor effective January 2020.
May 21, 2019
|
4 min read